Carbamazepine and other anti-epileptic drugs in the aquatic environment

• Autorzy: Rezka P. , Balcerzak W. , Kwaśny J.

Identyfikatory

DOI

10.4467/2353737XCT.15.189.4394

Warianty tytułu

PL

Karbamazepina i inne leki o działaniu przeciwpadaczkowym w środowisku wodnym

• Języki publikacji: EN

Abstrakty

EN

This paper is part of a series of publications discussing the prevalence of pharmaceuticals in the aquatic environment and the effectiveness of their removal and degradation during wastewater treatment processes. The paper discusses the problem of the presence of carbamazepine and other anti-epileptic drugs. The authors reviewed the basic characteristic parameters of these compounds, and based on the analysed literature data, the problem of anti-epileptic drugs, mainly carbamazepine, in the aquatic environment. Carbamazepine appears to be exceptionally persistent at municipal wastewater treatment plants as has been confirmed by current studies on its elimination and degradation, as well as reports on its presence in surface water, groundwater and even drinking water. The latest studies demonstrated highly effective removal of carbamazepine during oxidation processes. The application of these methods in real life situations should enable the effective protection of the aquatic environment.

PL

Artykuł jest częścią serii publikacji obejmujących zagadnienia występowania farmaceutyków w środowisku wodnym oraz skuteczności ich eliminacji i degradacji w procesach oczyszczania ścieków i uzdatniania wody. Praca przedstawia zagadnienia dotyczące karbamazepiny i innych leków przeciwpadaczkowych. Podano podstawowe parametry charakterystyczne dla opisywanych związków i w oparciu o dane literaturowe przybliżono problem, jakim jest występowanie leków przeciwpadaczkowych, a zwłaszcza karbamazepiny w środowisku wodnym. Karbamazepina okazuje się być farmaceutykiem wyjątkowo trwałym w warunkach oczyszczania ścieków miejskich, co potwierdzają dotychczasowe wyniki badań nad jej eliminacją i degradacją, a także doniesienia o obecności tego związku w wodach powierzchniowych, podziemnych, a nawet wodzie przeznaczonej do spożycia. Najnowsze badania wykorzystujące procesy utleniania wykazują bardzo wysoką skuteczność w eliminacji karbamazepiny, co stanowi dobry prognostyk w odniesieniu do ochrony środowiska wodnego.

Słowa kluczowe

EN

carbamazepine; antiepileptic drugs; wastewater; surface water; groundwater

PL

karbamazepina; leki przeciwpadaczkowe; ścieki; wody powierzchniowe; wody podziemne

• Wydawca: Wydawnictwo Politechniki Krakowskiej im. Tadeusza Kościuszki
• Czasopismo: Czasopismo Techniczne. Środowisko
• Rocznik: 2015
• Tom: Y. 112, iss. 1-Ś
• Strony: 111--118
• Opis fizyczny: Bibliogr. 36 poz., tab., rys.

Twórcy

autor

Rezka P.

• Faculty of Environmental Engineering, Cracow University of Technology

autor

Balcerzak W.

• Faculty of Environmental Engineering, Cracow University of Technology

autor

Kwaśny J.

• Faculty of Environmental Engineering, Cracow University of Technology

Bibliografia

• [1] Azzouz A., Ballesteros E., Influence of seasonal climate differences on the pharmaceutical, hormone and personal care product removal efficiency of a drinking water treatment plant, Chemosphere, Vol. 93, 2013, 2046-2054.
• [2] Balcerzak W., Rezka,P., Occurrence of anti-cancer drugs in the aquatic environment and efficiency of their removal – the selected issues, Technical Transactions, 1-Ś/2014, 11-18.
• [3] Buntner D., Żabczyński S., Miksch K., Usuwanie farmaceutyków ze ścieków, Chemik, Vol. 60, 2007, 120-124.
• [4] Cabeza Y., Candel, L., Ronen D., Teijon G., Monitoring the occurrence of emerging contaminants in treated wastewater and groundwater between 2008 and 2010. The Baix Llobregat (Barcelona, Spain), Hazardous Materials, Vol. 239–240, 2012, 32-39.
• [5] Camacho-Munoz D., Martin J., Santos J.L., Aparicio I., Alonso E., Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain), Journal of Hazardous Materials, Vol. 183, 2010, 602-608.
• [6] Carballa M., Manterola G., Larrea L., Ternes T., Omil F., Lema J.M., Influence of ozone pre-treatment on sludge anaerobic digestion: Removal of pharmaceutical and personal care products, Chemosphere, Vol. 67, 2007, 1444-1452.
• [7] Carballa M., Omil F., Ternes T., Lema J.M., Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge, Water Research, Vol. 41, 2007, 2139-2150.
• [8] Dong B., Kahl A., Cheng L., Vo H., Ruehl S., Zhang T., Snyder S., Saez A.E., Quanrud D., Arnold R.G., Fate of trace organics in a wastewater effluent dependent stream, Science of the Total Environment, Vol. 518–519, 2015, 479-490.
• [9] Huntscha S., Singer H.P., McArdell C.S., Frank C.E., Hollender J., Multiresidue analysis of 88 polar organic micropollutants in ground, surface and wastewater using online mixed-bed multilayer solid-phase extraction coupled to high performance liquid chromatography-tandem mass spectrometry, Journal of Chromatography A, Vol 1268, 2012, 74-83.
• [10] Kleywegt S., Pileggi V., Yang P., Hao C., Zhao X., Rocks C., Tchach S., Cheung P., Whitehead B., Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada - occurrence and treatment efficiency, Science of the Total Environment, Vol. 409, 2011, 1481-1488.
• [11] Kodesova R., Grabic R., Kocarek M., Klement A., Golovko O., Fer M., Nikodem A., Jaksik O., Pharmaceuticals’ sorptions relative to properties of thirteen different soils, Science of the Total Environment, Vol. 511, 2015, 435-443.
• [12] Kosma C.I., Lambropoulou D.A., Albanis T.A., Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece, Journal of Hazardous Materials, Vol. 179, 2010, 804-817.
• [13] Langford K.H., Thomas K.V., Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works, Environment International, Vol. 35, 2009, 766-770.
• [14] Lopez-Serna R., Jurado A., Vazquez-Sune E., Carrera J., Petrovic M., Barcelo D., Occurrence of 95 pharmaceuticalss and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain, Environmental Pollution, Vol. 174, 2013, 305-315.
• [15] Luo Y., Guo W., Ngo H.H., Nghiem L.D., Hai F.I., Zhang J., Liang S., Wang X.C., A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment, Science of the Total Environment, Vol. 473-474, 2014, 619-641.
• [16] Meffe R., de Bustamante I., Emerging organic contaminants in surface water and groundwater: A first overview of the situation in Italy, Science of the Total Environment, Vol. 481, 2014, 280-295.
• [17] Musolff A., Leschik S., Moder M., Strauch G., Reinstorf F., Schirmer M., Temporal and spatial patterns of micropollutants in urban receiving waters, Environmental Pollution, Vol. 157, 2009, 3069-3077.
• [18] Osenbruck K., Glaser H.R., Knoller K., Weise S.M., Moder M., Wennrich R., Sources and transport of selected organic micropollutants in urban groundwater underlying the city of Halle (Saale), Germany, Water Research, Vol. 41, 2007, 3259-3270.
• [19] Petrie B., Barden R., Kasprzyk-Hodern,B., A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring, Water Research, Vol. 72, 2015, 3-27.
• [20] Rohricht M., Krisam J., Weise U., Kraus U.R., During R.A., Elimination of carbamazepine, diclofenac and naproxen from treated wastewater by nanofiltration, Clean Soil Air Water, Vol. 37, 2009, 638-641.
• [21] Sacher F., Lange F.T., Brauch H.J., Blankenhorn I., Pharmaceuticals in groundwaters: analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany, Journal of Chromatography A, Vol. 938, 2001, 199-210.
• [22] Shao B., Chen D., Zhang J., Wu Y., Sun C., Determination of 76 pharmaceutical drugs by liquid chromatography–tandem mass spectrometry in slaughterhouse wastewater, Journal of Chromatography A, Vol. 1216, 2009, 8312-8318.
• [23] Simazaki D., Kubota R., Suzuki T., Akiba M., Nishimura T., Kunikane S., Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health, Water Research, Vol. 76, 2015, 187-200.
• [24] Stuart M., Lapworth D., Crane E., HartA., Review of risk from potential emerging contaminants in UK groundwater, Science of the Total Environment, Vol. 416, 2012, 1-21.
• [25] Tarcomnicu I., van Nuijs A.L.N., Simons W., Bervoets L., Blust R., Jorens P.G., Neels H., Covaci A., Simultaneous determination of 15 top-prescribed pharmaceuticals and their metabolites in influent wastewater by reversed-phase liquid chromatography coupled to tandem mass spectrometry, Talanta, Vol. 83, 2011, 795-803.
• [26] Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barcelo D., Hospital effluent - Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment, Science of the Total Environment, Vol. 430, 2012, 109-118.
• [27] Verlicchi P., Al Aukidy M., Zambello E., Occurrence of pharmaceutical compounds in Urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review, Science of the Total Environment, Vol. 429, 2012, 123-155.
• [28] Vulliet E., Cren-Olive C., Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption, Environmental Pollution, Vol. 159, 2011, 2929-2934.
• [29] Zhou Z., Jiang J.Q., Treatment of selected pharmaceuticals by ferrate (VI): Performance, kinetic studies and identification of oxidation products, Journal of Pharmaceutical and Biomedical Analysis, Vol. 106, 2015, 37-45.
• [30] Carbamazepine, www.drugbank.ca/drugs/DB00564, online: 31.05.2015.
• [31] Diazepam, www.drugbank.ca/drugs/DB00829, online: 31.05.2015.
• [32] Lorazepam, www.drugbank.ca/drugs/DB00186, online: 31.05.2015.
• [33] Phenytoin, www.drugbank.ca/drugs/DB00252, online: 31.05.2015.
• [34] Phenobarbital, www.drugbank.ca/drugs/DB01174, online: 31.05.2015.
• [35] Valproic acid, www.drugbank.ca/drugs/DB00313, online: 31.05.2015.
• [36] WHO Model List of Essential Medicines, www.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf, online: 31.05.2015.